ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

ClinicalTrials.gov ID: NCT07293260

Public ClinicalTrials.gov record NCT07293260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multi-center Study Evaluating the Safety, Tolerability, and Effect of Olpasiran on Coronary Artery Plaque Burden Assessed by Coronary Computed Tomography Angiography in Participants With Stable Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein(a)

Study identification

NCT ID
NCT07293260
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
406 participants

Conditions and interventions

Interventions

  • Olpasiran Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years to 80 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 22, 2026
Primary completion
Jun 14, 2028
Completion
Jun 14, 2028
Last update posted
Apr 15, 2026

2026 – 2028

United States locations

U.S. sites
6
U.S. states
6
U.S. cities
6
Facility City State ZIP Site status
Bridgeport Hospital Bridgeport Connecticut 06610 Recruiting
Jacksonville Center for Clinical Research Jacksonville Florida 32216 Recruiting
Midwest Heart and Vascular Specialists Overland Park Kansas 66211 Recruiting
Flourish Bowie Bowie Maryland 20715 Recruiting
Montefiore Medical Center - Bronx Philadelphia Pennsylvania 19141 Recruiting
Vital Heart and Vein Humble Texas 77338 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07293260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 15, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07293260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →